Circulatory System Dilated Cardiomyopathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1-patients with global dilation of left ventricle at the echocardiogram, New York Heart Association (NYHA) class II-III, 2-clinically stable without change in medication for last 30 days prior the study , 3-left ventricular end-diastolic dimension > 5.5cm and end-systolic diameter > 4.5cm, 6-left ventricular ejection fraction < 45%.
Exclusion criteria
Exclusion criteria: Chronic heart failure due to other causes, valvular disease requiring surgery, participating in other trials including physical exercise, chronic obstructive pulmonary disease, recent myocardial revascularization and disorders in the musculoskeletal system or other organs complicating physical activity and exercise training
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Left ventricular end Diastolic diameter LVEDD;and left ventricular ejection fraction (LVEF %);Left ventricular end Diastolic diameter LVEDD;and left ventricular ejection fraction (LVEF %);Left ventricular end systolic diameter LVESD;peak oxygen uptake(peakVO2);and ventilatory equivalent of CO2 at anaerobic threshold ( EqCO2 at AT);Maximum inspiratory pressure (IPMAX) | — |
Countries
Egypt
Contacts
Assistant professor of Physical Therapy, Faculty of Physical Therapy, Cairo University